Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses.
The pharmacokinetics of once-daily oral levofloxacin (study A) or intravenous levofloxacin (study B) in 40 healthy male volunteers were investigated in two separate randomized, double-blind, parallel-design, placebo-controlled studies. Levofloxacin at 500 mg or placebo was administered orally or int...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1997
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC164102/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9333057/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.10.2256 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
